Allergy Therapeutics PLC - News Announcement - Allergy Therapeutics - Grant of Options
Allergy Therapeutics PLC
29 September 2011
Provisional Grant of Options
Allergy Therapeutics plc ('the Company') announces that, pursuant to the Allergy Therapeutics plc Long Term Share Incentive Plan ('LTIP'), on 7 December 2010 provisional shares of 0.1 pence each in the share capital of the Company were awarded to the following Board of Directors, Mr Manuel Llobet (Chief Executive Officer) and Mr Ian Postlethwaite (Finance Director) at nil cost, as follows:
|
Director |
Number of provisional shares awarded |
Date of distribution |
Total provisional shares held under LTIPs |
|
Manuel Llobet |
720,000 |
7 December 2010 |
1,470,000 |
|
Ian Postlethwaite |
360,000 |
7 December 2010 |
960,000 |
The distribution of these ordinary shares of 0.1 pence each under the LTIP is conditional on the Company's performance over the course of the next three years.
For further information
Allergy Therapeutics +44 (0) 1903 845 820
Manuel Llobet, Chief Executive
www.allergytherapeutics.com
Nomura Code Securities +44 (0) 207 776 1200
Juliet Thompson/ Clare Terlouw
This information is provided by RNS